⚡ Neurological / SeizureIV Infusion
BRIUMVI
Ublituximab
CD20-directed antibody used to treat relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome and relapsing-remitting disease.
Form
IV Infusion
Uses
3
Side effects
4
Category
Neurological
01
What is BRIUMVI used for?
- Relapsing forms of multiple sclerosis
- Clinically isolated syndrome
- Active secondary progressive multiple sclerosis
02
Ublituximab side effects
The following side effects have been reported for Ublituximab. Their order does not indicate how often an effect occurs.
Infusion reactions
Upper respiratory infections
Decreased immunoglobulins
Headache
03
Ublituximab warnings & precautions
- Increased infection risk
- Monitor immunoglobulin levels periodically
- Live vaccines should be completed before treatment
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand BRIUMVI in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.